Skip to content
Clinical Trials – home
Verifiedinfo

Rezeknes Slimnica SIA

Latvia 18. Novembra Iela 41, LV-4601 Rezekne, Latvia

  • 1 trial recruiting
  • Ischaemic stroke · Transient ischaemic attack · Cerebrovascular accident prophylaxis
  • Adult patients

About Specializations

Rezeknes Slimnica SIA in Rezekne, Latvia specialises in clinical trials of conditions such as Ischaemic stroke, Transient ischaemic attack, Cerebrovascular accident prophylaxis, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases Research

At Rezeknes Slimnica SIA, clinical trials in cardiovascular diseases focus on common and serious conditions such as heart disease and the prevention of ischemic stroke after a recent stroke or high-risk transient ischemic attack. The research is designed to evaluate new treatment options and improve outcomes for patients at elevated risk of future cardiovascular events.

  • Studying approaches to prevent recurrent stroke in patients after acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack
  • Assessing whether new therapies can better reduce clot-related stroke risk alongside standard antiplatelet treatment
  • Evaluating treatment strategies for patients with heart failure and related cardiovascular complications

The site’s internal medicine team is contributing to research that aims to improve both efficacy and safety in cardiovascular care, with attention to preventing major events such as stroke and heart failure-related death.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
18. Novembra Iela 41LV-4601 RezekneLatvia
Recruiting now
1 trial
Conditions studied
3
Partner status
Verified

More sites in RezekneLatvia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Ischaemic stroke+2

Not recruiting
Investigational
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.